H. B. Fuller (NYSE:FUL) Upgraded by Wall Street Zen to “Buy” Rating

Wall Street Zen upgraded shares of H. B. Fuller (NYSE:FUL) from a hold rating to a buy rating in a research report released on Sunday morning.

FUL has been the topic of several other reports. Vertical Research raised H. B. Fuller from a “hold” rating to a “strong-buy” rating in a research note on Friday. Weiss Ratings restated a “hold (c)” rating on shares of H. B. Fuller in a report on Monday, December 29th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of H. B. Fuller in a research report on Friday, January 16th. Citigroup decreased their price objective on shares of H. B. Fuller from $76.00 to $67.00 and set a “buy” rating for the company in a research note on Thursday, March 19th. Finally, UBS Group dropped their price objective on shares of H. B. Fuller from $66.00 to $63.00 and set a “neutral” rating for the company in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $64.75.

H. B. Fuller Trading Down 0.2%

Shares of FUL opened at $59.04 on Friday. H. B. Fuller has a twelve month low of $47.56 and a twelve month high of $68.63. The firm has a market capitalization of $3.22 billion, a P/E ratio of 19.68, a price-to-earnings-growth ratio of 0.88 and a beta of 1.07. The company has a current ratio of 1.92, a quick ratio of 1.15 and a debt-to-equity ratio of 1.01. The stock’s fifty day simple moving average is $61.03 and its 200 day simple moving average is $60.05.

H. B. Fuller (NYSE:FUL) last posted its quarterly earnings results on Wednesday, March 25th. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.56 by $0.01. The firm had revenue of $770.84 million during the quarter, compared to the consensus estimate of $787.77 million. H. B. Fuller had a return on equity of 11.84% and a net margin of 4.62%.The firm’s quarterly revenue was down 2.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.54 earnings per share. On average, equities research analysts forecast that H. B. Fuller will post 4.07 earnings per share for the current year.

H. B. Fuller Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, February 19th. Investors of record on Thursday, February 5th were issued a dividend of $0.235 per share. This represents a $0.94 annualized dividend and a dividend yield of 1.6%. The ex-dividend date was Thursday, February 5th. H. B. Fuller’s dividend payout ratio (DPR) is presently 31.33%.

Hedge Funds Weigh In On H. B. Fuller

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Norges Bank acquired a new stake in H. B. Fuller in the fourth quarter valued at approximately $44,203,000. Cooke & Bieler LP lifted its position in shares of H. B. Fuller by 94.9% during the third quarter. Cooke & Bieler LP now owns 1,481,030 shares of the specialty chemicals company’s stock worth $87,795,000 after purchasing an additional 721,100 shares in the last quarter. UBS Group AG lifted its position in shares of H. B. Fuller by 200.8% during the third quarter. UBS Group AG now owns 820,871 shares of the specialty chemicals company’s stock worth $48,661,000 after purchasing an additional 548,017 shares in the last quarter. Verition Fund Management LLC boosted its stake in shares of H. B. Fuller by 1,379.5% in the fourth quarter. Verition Fund Management LLC now owns 383,955 shares of the specialty chemicals company’s stock valued at $22,830,000 after purchasing an additional 358,003 shares during the period. Finally, Goldman Sachs Group Inc. boosted its position in H. B. Fuller by 52.3% in the 4th quarter. Goldman Sachs Group Inc. now owns 820,255 shares of the specialty chemicals company’s stock valued at $48,772,000 after buying an additional 281,707 shares during the last quarter. Hedge funds and other institutional investors own 95.93% of the company’s stock.

H. B. Fuller News Summary

Here are the key news stories impacting H. B. Fuller this week:

• Positive Sentiment: Company announced a global price hike of at least 10% starting April to address petrochemical supply constraints and rising input costs — a measure likely to help margins and cash flow. Article Title
• Positive Sentiment: Management issued FY guidance of $4.55–$4.90 in EPS and mid-single-digit revenue growth, signaling confidence that price actions and cost management will offset supply volatility. Article Title
• Positive Sentiment: Q1 EPS of $0.57 beat consensus ($0.56), and management reiterated improved profitability drivers; several outlets characterize the quarter as a solid start despite top-line pressure. Article Title
• Neutral Sentiment: Full earnings call transcript, slide deck and presentations are available for investors to review detailed segment results and management commentary. Earnings Call Transcript
• Negative Sentiment: Revenue missed estimates ($770.8M reported vs. ~$787.8M consensus) and was down 2.3% year-over-year, a near-term headwind for growth expectations. Article Title
• Negative Sentiment: UBS lowered its price target from $66 to $63 and moved to a neutral rating, which could cap upside momentum and signal analyst caution. Article Title
• Negative Sentiment: Some analysts expressed reduced optimism after the quarter, highlighting mixed signals (beat on EPS vs. weaker revenue and supply risks) that may keep multiple compression or volatility in place. Article Title

H. B. Fuller Company Profile

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.